Littig B, Frewer A (Hrsg.) (2009): Ethische Fragen genetischer Beratung. Klinische Erfahrungen, Forschungsstudien und soziale Perspektiven. Peter Lang, Frankfurt am Main u.a. Rieder A, Lohff B (Hrsg.) [...] Geschlechtsspezifische Aspekte für die klinische Praxis. Springer, Wien/ New York. Dörries A, Neitzke G, Simon A., Vollmann J (Hrsg.) (2008): Klinische Ethikberatung. Ein Praxisbuch. Kohlhammer, Stuttgart [...] besetzten Europa 1939-1945 (Das Private im Nationalsozialismus, Bd. 5), Wallstein Verlag, Göttingen 2022. A.-H. Seidlein, S. Salloch (Eds.) Ethical Challenges for Healthcare Practices at the End of Life: Int

cord blood (CB) transplant, a solid organ transplant or a transplant from a virus-seronegative donor no T-cell donor will be available. For this reason, a rapid recruitment of a respective T-cell donor and [...] authorities was granted by March 27th, 2014. If you have a patient, who is in need of a third party T-cell donor from alloCELL registry and/or a personalized antiviral T-cell immunotherapeutics monitoring [...] and an established method for a fast manufacturing of antiviral T cells without long-term ex vivo culture are of great importance. A registry of potential third-party T-cell donors (allogeneic cell registry

Treatment of hand infections using WALANT when the anesthesiologist is not available A. Enechukwu1, A. Jokuszies1, S. Könneker1, P. Vogt1 1Medizinische Hochschule Hannover Background: Aim of this study was to [...] 11 patients (70,6%). We discovered a foreign body as cause of the hand infection in one individual. There was no case of accompanying osteomyelitis. One patient had a fresh fracture. 4 patients had diabetes [...] patients were admitted, with a mean stay of 4,2 days, while the rest were treated as outpatients. The patients were discharged on non-opioid analgesics with 3 receiving a combination of 2. There was no

patients will be included in this study and will undergo a central histologic evaluation. The AG clinical studies in breast cancer serves as a reference pathology unit and tumor bank for the ADAPT-TN-III [...] paclitaxel + trastuzumab + pertuzumab). Primary end points include pCR-rates and 3-year distant-disease-free survival (dDFS). ADAPT-HER2-IV is a prospective, multicenter, randomized open-label Phase-II trial [...] (2023-2024) Collagenous spherulosis (CS) is a benign mammary lesion. Its tumorigenesis is incompletely understood. CS often affects mammary lobules and is characterized by a mixture of epithelial cells with my

herzlich willkommen sind! Sprechen Sie uns an: Kathrin Roth . Ihr Studiendekanat Medizin Studium von A-Z A Abmeldung von einer Modulprüfung Adressänderung Aktuelles Alumni - MHH-ALumni e.V. AMBOSS (kostenlose [...] Vorsorgeuntersuchung arznei-telegramm - Kostenloses Digitalabo für Studierende der Humanmedizin AStA (Allgemeiner Studierendenausschuss) Attest (Erkrankung bei Prüfungen) | Fristen ►siehe Rechte und Pflichten [...] nach dem 3. Studienjahr (fehlende M1-Äquvalenz) Notfallsozialfonds für Studierende der MHH O Ordnungen P PJ-OSCE Podcast Praktisches Jahr (PJ) Prüfungen Prüfungsformate (siehe Anlage 3 und 4 der Prüfungsordnung

;-) https://www.youtube.com/watch?v=A0VYJynpjmA Portrait of a PhD student (mix of English/German) https://www.youtube.com/watch?v=GCE8rCOSZJI&list=PLhkNEXoq-CGTxUZu19rGcP9QLhfWczGJo&index=5 Cluster of Excellence [...] EPI3aZFbA&index=4 Some quotations: "Structures of HBRS are already established in such an excellent way that one could expect a successful and sustainable support of young researchers as well as a continuous [...] program 'Molecular Medicine' is a model for all future PhD programs in Germany" (Prof. Winnacker, DFG, June 2002) "With the foundation of the MD/PhD program, the MHH takes a leading role in Germany. The program

Patientensicherheit. Im Rahmen einer Vielzahl von Projekten, die von verschiedenen Drittmittelgebern, u.a. von der Deutschen Forschungsgemeinschaft (DFG) im Rahmen des Sonderforschungsbereichs 599 „Zukunftsfähige [...] können neben einem Fluoreszenz Imaging System zur In-vivo-Untersuchung von Entzündungsreaktionen oder pH-Wertverschiebungen im Kleintier in Kooperation mit dem Institut für Versuchstierkunde der MHH ein

Palliative Care. Publikationen Aleksandrina Skvortsova A, Stiel S, Afshar K, Röwer HAA, Bausewein C, Hartigan I, Saab MM, Martins Pereira S, Hernández-Marrero P, Hrdlička J, Wild J, Rusinová K, Loučka M, Hrdličková [...] Acceptability of virtual reality for training health professions students in serious illness communication: A cross-sectional study with educators. PEC Innovation. 2025;7:100411. https://doi.org/10.1016/j.pecinn

results of a longitudinal study. (Kongress ISPOG 2010) Noeres D, von Garmissen A, Neises M. Geyer S. Breast Cancer Knowledge in Self-Help Groups. (Kongress ESHMS 2010, Ghent) Noeres D, Prochnow A, Geyer S [...] Jaunzeme J, Geyer S (2013). Return to work after treatment for primary breast cancer over a six-year period: Results from a prospective study comparing patients with the general population. Supportive Care in [...] e zu Life-Events bei Patientinnen mit Brustkrebs. Das Gesundheitswesen, 71-A50 dx.doi.org/10.1055/s-0029-1239100 Garmissen A v (2009). Sinnstiftende Faktoren, religiöse Werthaltungen und Krankheitsbwältigung

regulate a single gene, DNA or protein but interfere with complex cellular signal networks. A systems-level approach is required to see beyond the tip of the iceberg of this regulation. Our lab employs a broad [...] Selective inhibition of miRNA processing by a herpesvirus-encoded miRNA. -> Nature 605(7910):539-544. DOI: 10.1038/s41586-022-04667-4 Erhard F, Saliba AE, Lusser A, Toussaint C, Hennig C, Prusty BK, Kirschenbaum [...] ) (PMID: 29529017, PMID: 37172056). We also developed a new nomenclature to incorporate the novel gene products into the existing nomenclature. A particularly interesting finding from ribosome profiling